Published in Eval Rev on December 01, 2000
Managing addiction as a chronic condition. Addict Sci Clin Pract (2007) 3.17
Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"? Health Serv Res (2006) 2.14
Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI. Health Serv Res (2002) 1.48
What are your priorities right now? Identifying service needs across recovery stages to inform service development. J Subst Abuse Treat (2009) 1.21
Using administrative data for longitudinal substance abuse research. J Behav Health Serv Res (2008) 1.08
Cost-effectiveness analysis of four interventions for adolescents with a substance use disorder. J Subst Abuse Treat (2007) 1.05
The effect of substance abuse treatment on Medicaid expenditures among general assistance welfare clients in Washington state. Milbank Q (2006) 0.96
Public alcohol policy: current directions and new opportunities. Clin Pharmacol Ther (2008) 0.91
Does the impact of managed care on substance abuse treatment services vary by provider profit status? Health Serv Res (2005) 0.82
Health-care service utilization in substance abusers receiving contingency management and standard care treatments. Addiction (2012) 0.80
Preferences for Aftercare Among Persons Seeking Short-Term Opioid Detoxification. J Subst Abuse Treat (2015) 0.78
Interim versus standard methadone treatment: a benefit-cost analysis. J Subst Abuse Treat (2013) 0.78
Telephone-based continuing care counseling in substance abuse treatment: Economic analysis of a randomized trial. Drug Alcohol Depend (2015) 0.75
An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis (1980) 14.25
New data from the Addiction Severity Index. Reliability and validity in three centers. J Nerv Ment Dis (1985) 9.12
Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr (1993) 5.08
Alcohol interventions in a trauma center as a means of reducing the risk of injury recurrence. Ann Surg (1999) 4.84
Alcohol interventions in trauma centers. Current practice and future directions. JAMA (1995) 3.54
Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci U S A (1997) 3.26
The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun (2001) 2.89
Myths about the treatment of addiction. Lancet (1996) 2.58
Internal validity of Project MATCH treatments: discriminability and integrity. J Consult Clin Psychol (1998) 2.56
Classical conditioning in drug-dependent humans. Ann N Y Acad Sci (1992) 2.28
Predicting response to alcohol and drug abuse treatments. Role of psychiatric severity. Arch Gen Psychiatry (1983) 2.25
Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr (1993) 2.23
Supplemental social services improve outcomes in public addiction treatment. Addiction (1998) 2.21
A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP). J Subst Abuse Treat (1998) 2.15
Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome. N Engl J Med (1989) 2.11
Cloning of the gamma-aminobutyric acid (GABA) rho 1 cDNA: a GABA receptor subunit highly expressed in the retina. Proc Natl Acad Sci U S A (1991) 2.10
Therapist success and its determinants. Arch Gen Psychiatry (1985) 2.00
Naltrexone pharmacotherapy for opioid dependent federal probationers. J Subst Abuse Treat (1998) 1.98
Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull (2001) 1.97
The therapeutic alliance and its relationship to alcoholism treatment participation and outcome. J Consult Clin Psychol (1997) 1.85
Structure and organization of two linked ribosomal protein genes in yeast. Nucleic Acids Res (1984) 1.81
Are supplementary services provided during methadone maintenance really cost-effective? Am J Psychiatry (1997) 1.81
Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc Natl Acad Sci U S A (1992) 1.79
Abstinent opiate abusers exhibit conditioned craving, conditioned withdrawal and reductions in both through extinction. Br J Addict (1986) 1.69
Reliability and validity of the Addiction Severity Index with a homeless sample. J Subst Abuse Treat (1995) 1.60
Acetylcholine stimulation of the phosphodiesteratic cleavage of guinea pig brain phosphoinositides. Life Sci (1968) 1.58
Classically conditioned responses in opioid and cocaine dependence: a role in relapse? NIDA Res Monogr (1988) 1.56
Can you trust patient self-reports of drug use during treatment? Drug Alcohol Depend (1994) 1.53
Effect of random versus nonrandom assignment in a comparison of inpatient and day hospital rehabilitation for male alcoholics. J Consult Clin Psychol (1995) 1.52
The enzymic hydrolysis of phosphatidyl inositol by guinea pig brain: Sub-cellular distribution and hydrolysis products. J Neurochem (1969) 1.49
Interviewer severity ratings and composite scores of the ASI: a further look. Drug Alcohol Depend (1994) 1.49
Antisocial personality disorder in patients with substance abuse disorders: a problematic diagnosis? Am J Psychiatry (1990) 1.48
Relation of stressors and depressive symptoms to clinical progression of viral illness. Am J Psychiatry (1996) 1.43
Psychotherapy for opiate addicts. Does it help? Arch Gen Psychiatry (1983) 1.42
Relationship between follow-up rates and treatment outcomes in substance abuse research: more is better but when is "enough" enough? Addiction (2000) 1.42
Increased effectiveness of substance abuse treatment. A prospective study of patient-treatment "matching". J Nerv Ment Dis (1983) 1.40
Implementing treatment and protecting the validity of the independent variable in treatment matching studies. J Stud Alcohol Suppl (1994) 1.40
Does clinical case management improve outpatient addiction treatment. Drug Alcohol Depend (1999) 1.39
Conditioned craving and arousal in cocaine addiction: a preliminary report. NIDA Res Monogr (1988) 1.38
Therapeutic play. J Am Acad Child Adolesc Psychiatry (1997) 1.38
Addiction severity index data from general membership and treatment samples of HMO members. One case of norming the ASI. J Subst Abuse Treat (2000) 1.37
Combat-related posttraumatic stress disorder and severity of substance abuse in Vietnam veterans. J Stud Alcohol (1992) 1.36
Regulation of the mouse alpha A-crystallin gene: isolation of a cDNA encoding a protein that binds to a cis sequence motif shared with the major histocompatibility complex class I gene and other genes. Mol Cell Biol (1990) 1.36
A cocaine-positive baseline urine predicts outpatient treatment attrition and failure to attain initial abstinence. Drug Alcohol Depend (1997) 1.35
Detection of acute alcohol intoxication and chronic alcohol dependence by trauma center staff. J Trauma (1999) 1.35
Interpreting the significance of drinking by alcohol-dependent liver transplant patients: fostering candor is the key to recovery. Liver Transpl (2000) 1.34
Multidimensional assessment of perceived treatment-entry pressures among substance abusers. Psychol Addict Behav (2001) 1.34
Transcriptional regulation of ribosomal proteins during a nutritional upshift in Saccharomyces cerevisiae. Mol Cell Biol (1986) 1.34
The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug Alcohol Depend (2001) 1.33
Acetylcholine action: biochemical aspects. Science (1969) 1.32
Sociopathy and psychotherapy outcome. Arch Gen Psychiatry (1985) 1.31
Developing a national addiction treatment information system. An introduction to the Drug Evaluation Network System. J Subst Abuse Treat (1999) 1.29
Conditioned responses in a methadone population. A comparison of laboratory, clinic, and natural settings. J Subst Abuse Treat (1986) 1.28
Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome. Hum Mol Genet (2000) 1.26
Evaluation of a video-supplement to informed consent: injection drug users and preventive HIV vaccine efficacy trials. AIDS Educ Prev (1997) 1.26
Private substance abuse treatments: are some programs more effective than others? J Subst Abuse Treat (1993) 1.25
Assembly and use of a broadly applicable neural cDNA microarray. Restor Neurol Neurosci (2001) 1.24
The development of the Comprehensive Addiction Severity Index for Adolescents (CASI-A). An interview for assessing multiple problems of adolescents. J Subst Abuse Treat (1995) 1.24
Can induced moods trigger drug-related responses in opiate abuse patients? J Subst Abuse Treat (1994) 1.24
Effectiveness and costs of inpatient versus day hospital cocaine rehabilitation. J Nerv Ment Dis (1994) 1.23
Psychotherapy in community methadone programs: a validation study. Am J Psychiatry (1995) 1.23
Twenty-five strategies for improving the design, implementation and analysis of health services research related to alcohol and other drug abuse treatment. Addiction (2000) 1.22
High-risk sexual behaviors of intravenous drug users in- and out-of-treatment: implications for the spread of HIV infection. Am J Drug Alcohol Abuse (1992) 1.21
Treatment goals, continuity of care, and outcome in a day hospital substance abuse rehabilitation program. Am J Psychiatry (1994) 1.21
Gene expression profile in early stage of retinoic acid-induced differentiation of human SH-SY5Y neuroblastoma cells. Restor Neurol Neurosci (2001) 1.20
Predictors of participation in aftercare sessions and self-help groups following completion of intensive outpatient treatment for substance abuse. J Stud Alcohol (1998) 1.19
Prediction of attrition from day hospital treatment in lower socioeconomic cocaine-dependent men. Drug Alcohol Depend (1996) 1.17
Employment outcomes among AFDC recipients treated for substance abuse in Washington State. Milbank Q (2000) 1.17
Acetylcholine-stimulated phosphodiesteratic cleavage of phosphoinositides: hypothetical role in membrane depolarization. Ann N Y Acad Sci (1969) 1.13
Alcohol abuse in urban Indian adolescents and women: a longitudinal study for assessment and risk evaluation. Am Indian Alsk Native Ment Health Res (1996) 1.12
Practical guidelines for performing alcohol interventions in trauma centers. J Trauma (1997) 1.12
Addictive behaviors: etiology and treatment. Annu Rev Psychol (1988) 1.11
Is treatment for substance abuse effective? JAMA (1982) 1.10
Ectodysplasin-A1 is sufficient to rescue both hair growth and sweat glands in Tabby mice. Hum Mol Genet (2001) 1.10
Relationship of perceived competencies, perceived social support, and gender to substance use in young adolescents. J Am Acad Child Adolesc Psychiatry (1997) 1.10
Length of stay, patient severity and treatment outcome: sample data from the field of alcoholism. J Stud Alcohol (1992) 1.10
Pharmacological and behavioral treatments of cocaine dependence: controlled studies. J Clin Psychiatry (1988) 1.10
Coerced treatment for substance abuse problems detected through workplace urine surveillance: is it effective? J Subst Abuse (1996) 1.09
Predicting readmission to substance abuse treatment using state information systems. The impact of client and treatment characteristics. J Subst Abuse (2000) 1.08
Evaluation of the Jebsen hand function test for use in patients with rheumatoid arthritis [corrected]. Arthritis Care Res (1994) 1.08
Sources of motivation for abstinence: a replication analysis of the reasons for quitting questionnaire. Addict Behav (2001) 1.07
Risk factors for needle sharing among methadone-treated patients. Am J Psychiatry (1991) 1.06
Alcohol use before and after traumatic head injury. Ann Emerg Med (1995) 1.06
Diazepam use among methadone maintenance patients: patterns and dosages. Drug Alcohol Depend (1981) 1.05
Is the Addiction Severity Index a reliable and valid assessment instrument among clients with severe and persistent mental illness and substance abuse disorders? Community Ment Health J (1997) 1.05
Conceptualizations of relapse: a summary of psychological and psychobiological models. Addiction (1996) 1.05
Completion rates of clients discharged from drug and alcohol treatment programs in Washington State. Am J Public Health (1994) 1.05
Determinants of condom use among intravenous drug users. AIDS (1993) 1.04
Development of a "treatment program" descriptor: the addiction treatment inventory. Subst Use Misuse (2001) 1.03
Will preventive HIV vaccine efficacy trials be possible with female injection drug users? J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.03
The relationship of alcohol use to cocaine relapse in cocaine dependent patients in an aftercare study. J Stud Alcohol (1999) 1.02
Personality disorders and treatment outcome in methadone maintenance patients. J Nerv Ment Dis (1996) 1.01
Twelve-month abstinence from alcohol and long-term drinking and marital outcomes in men with severe alcohol problems. J Stud Alcohol (1998) 1.00
Integrating skills training and motivational therapies. Implications for the treatment of substance dependence. J Subst Abuse Treat (1999) 1.00
Personality subtypes among driving-while-intoxicated offenders: relationship to drinking behavior and driving risk. J Consult Clin Psychol (1982) 1.00
'Research' versus 'real-world' patients: representativeness of participants in clinical trials of treatments for cocaine dependence. Drug Alcohol Depend (1999) 1.00
Contrasts between admitters and deniers of drug use. J Subst Abuse Treat (2000) 1.00
Psychiatric comorbidity: prevalence in methadone maintenance treatment. Am J Drug Alcohol Abuse (1996) 0.99